FDA announces guidelines for polymyxin, vecuronium recall
On Jan. 12, The U.S. Food and Drug Administration announced that Bedford Laboratories states certain vials of polymyxin and vecuronium bromide, recalled because of…
*By submitting your e-mail, you are opting in to receiving information from Healthcom Media and Affiliates. The details, including your email address/mobile number, may be used to keep you informed about future products and services.